Home » Topics » BioWorld Science

BioWorld Science
RSS

New broad spectrum antivirals discovered at FORGE Life Science

May 13, 2019

Polyphor temporarily halts enrollment in phase III studies of murepavadin

May 13, 2019

Gene editing restores skin functionality in blistering disease

May 13, 2019

SHR-1210 plus capecitabine and oxaliplatin shows promising safety and efficacy in GC/GEJ

May 13, 2019

Investigators present phase II data for CBT-001 for the treatment of pterygia

May 13, 2019

AAI 2019: T-cell therapy could be brought within reach of "virtually all" patients

May 13, 2019

LY-3154207 demonstrates linear plasma PK and promising safety in healthy volunteers

May 13, 2019

Merck & Co. discovers dual TBK1/IKBKE inhibitors

May 13, 2019

NIH initiates LATITUDE study to evaluate long-acting HIV medication

May 13, 2019

FORMA Therapeutics identifies new HDAC6 inhibitors

May 13, 2019

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...